161 related articles for article (PubMed ID: 28211589)
1. The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy.
Rivosecchi RM; Kane-Gill SL; Garavaglia J; MacLasco A; Johnson H
Int J Pharm Pract; 2017 Dec; 25(6):463-465. PubMed ID: 28211589
[TBL] [Abstract][Full Text] [Related]
2. Impact of Vitamin K Administration on INR Changes and Bleeding Events Among Patients With Cirrhosis.
Meyer AV; Green M; Pautler HM; Korenblat K; Deal EN; Thoelke MS
Ann Pharmacother; 2016 Feb; 50(2):113-7. PubMed ID: 26586854
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.
Al Sulaiman K; Al Mutairi M; Al Harbi O; Al Duraihim A; Aldosary S; Al Khalil H; Al Shaya A; Al Harbi S; Alotaibi N; Al Aamer K; Vishwakarma R; Al Asiri M; Aljuhani O; Al Katheri A; Al Bekairy AM
Clin Appl Thromb Hemost; 2021; 27():10760296211050923. PubMed ID: 34806430
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
5. The coagulopathy of liver disease: does vitamin K help?
Saja MF; Abdo AA; Sanai FM; Shaikh SA; Gader AG
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):10-7. PubMed ID: 23080365
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Response to High-Dose Intravenous Vitamin K Administration.
Chapman AR; Yerke JR; Lumpkin M; Rudoni MA; Militello M; Wang L; Bass SN
Ann Pharmacother; 2023 Oct; 57(10):1178-1184. PubMed ID: 36803019
[TBL] [Abstract][Full Text] [Related]
7. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
[TBL] [Abstract][Full Text] [Related]
8. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
[TBL] [Abstract][Full Text] [Related]
9. Elevated International Normalized Ratio associated with long-term azithromycin therapy in a child with cerebral palsy.
Stork CM; Marraffa JM; Ragosta K; Wojcik SM; Angelino KL
Am J Health Syst Pharm; 2011 Jun; 68(11):1012-4. PubMed ID: 21593229
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
[TBL] [Abstract][Full Text] [Related]
11. Intravenous phytonadione administered orally in reducing warfarin-related coagulopathy.
Rice JH; Akpunonu P; Davis GA; Dugan A; Litteral J; Webb AN; Wiegand A; Bailey A; Baum RA
Clin Toxicol (Phila); 2022 Apr; 60(4):530-532. PubMed ID: 34751053
[TBL] [Abstract][Full Text] [Related]
12. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
14. Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.
Zeynelabidin S; Klouwer FCC; Meijers JCM; Suijker MH; Engelen M; Poll-The BT; van Ommen CH
J Inherit Metab Dis; 2018 Mar; 41(2):249-255. PubMed ID: 29139025
[TBL] [Abstract][Full Text] [Related]
15. Prolonged coagulopathy after brodifacoum exposure.
Underwood EL; Sutton J; Ellis IK; Qualls B; Zamber J; Walker BN
Am J Health Syst Pharm; 2014 Apr; 71(8):639-42. PubMed ID: 24688037
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
Gunther KE; Conway G; Leibach L; Crowther MA
Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation therapy in liver cirrhosis].
Garcia-Conde Bru FJ; Rodrigo Gomez JM
Rev Esp Enferm Apar Dig; 1969 May; 28(5):695-702. PubMed ID: 5344674
[No Abstract] [Full Text] [Related]
18. The use of vitamin K for coagulopathy in critically ill children.
Smith CJ; Valencia R; Sierra CM; Lopez M
Hosp Pract (1995); 2023 Dec; 51(5):262-266. PubMed ID: 37933498
[TBL] [Abstract][Full Text] [Related]
19. Impact of Vitamin K Administration on Elevated International Normalized Ratio in Chronic Liver Disease.
Smith CB; Hennessey EK; Crossey CD; Crannage AJ
Clin Appl Thromb Hemost; 2023; 29():10760296231164642. PubMed ID: 37093741
[TBL] [Abstract][Full Text] [Related]
20. [Therapy with heparin in active liver cirrhosis (author's transl)].
Fischer M; Gauss P; Korp W; Nobis H; Schnack H; Weissmann A
Leber Magen Darm; 1973 Dec; 3(6):253-6. PubMed ID: 4785771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
